• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    54 Biggest Movers From Yesterday

    4/20/22 5:43:34 AM ET
    $ACC
    $AIM
    $ANNX
    $ARQQ
    Real Estate Investment Trusts
    Real Estate
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACC alert in real time by email

    Gainers

    • Checkmate Pharmaceuticals, Inc. (NASDAQ:CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced a deal to acquire the company for $10.50 per share in cash.
    • Sono Group N.V. (NASDAQ:SEV) climbed 65.2% to close at $7.60.
    • Sharps Technology, Inc. (NASDAQ:STSS) shares gained 40.5% to close at $2.43 after dipping 18% on Monday. The company recently priced its IPO at $4.25 per share.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) gained 37% to close at $0.2010 as the company posted a narrower FY21 loss.
    • Baosheng Media Group Holdings Limited (NASDAQ:BAOS) rose 33.3% to close at $0.78.
    • Terran Orbital Corporation (NYSE:LLAP) gained 28.4% to settle at $4.98.
    • MedAvail Holdings, Inc. (NASDAQ:MDVL) jumped 26.4% to close at $2.73.
    • Axsome Therapeutics, Inc. (NASDAQ:AXSM) climbed 25.1% to close at $40.92 after the company announced it received and agreed to Postmarketing Requirements/Commitments proposed by the FDA with respect to the NDA for its AXS-05.
    • Charge Enterprises, Inc. (NASDAQ:CRGE) jumped 24.1% to close at $7.93.
    • Zymergen Inc. (NASDAQ:ZY) gained 22.6% to close at $2.01.
    • Super Micro Computer, Inc. (NASDAQ:SMCI) gained 22% to close at $44.65 after the company raised its Q3 guidance above analyst estimates.
    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) rose 21.9% to close at $1.45. Clarus Therapeutics reported presentation of new data for its JATENZO at Androgen Society Annual Meeting Apr. 23 at 10:15 a.m. EDT.
    • Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) gained 20.9% to settle at $1.33 after the company announced results from its OTC draft label comprehension study for STENDRA.
    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) rose 18.5% to close at $4.10.
    • AIM ImmunoTech Inc. (NYSE:AIM) surged 15.5% to close at $1.12. AIM ImmunoTech recently announced the presentation of positive data from a Phase 1 study of Ampligen in metastatic triple-negative breast cancer.
    • Leap Therapeutics, Inc. (NASDAQ:LPTX) gained 15.4% to settle at $1.65.
    • Tricida, Inc. (NASDAQ:TCDA) rose 15.4% to close at $11.75.
    • Candel Therapeutics, Inc. (NASDAQ:CADL) climbed 15% to close at $5.51.
    • ThredUp Inc. (NASDAQ:TDUP) jumped 14.4% to close at $8.81.
    • Silvergate Capital Corporation (NYSE:SI) climbed 13.2% to settle at $131.67 after the company reported better-than-expected Q1 EPS results.
    • Evoke Pharma, Inc. (NASDAQ:EVOK) gained 13.2% to close at $0.4245. Evoke Pharma reported approval of its GIMOTI to Texas Medicaid Preferred Drug List.
    • American Campus Communities, Inc. (NYSE:ACC) climbed 12.5% to close at $64.80 after the company announced Blackstone Core+ Perpetual Capital Vehicles will acquire the company for $65.47 per share in cash.
    • Gogoro Inc. (NASDAQ:GGR) rose 11.8% to close at $8.94. Gogoro’s Chief Executive Officer Horace Luke said that the company has an adequate amount of chips to meet its needs, Reuters reported.
    • Navidea Biopharmaceuticals, Inc. (NASDAQ:NAVB) gained 11.7% to close at $0.99 after the company announced the regulatory approval of Lymphoaim by the Central Drugs Standard Control Organisation in India.
    • Annexon, Inc. (NASDAQ:ANNX) gained 11.4% to close at $2.35. Annexon CEO Douglas Love reported the purchase of 60,000 shares at an average price of $2.45 per share.
    • Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) gained 9.2% to close at $3.20.
    • Party City Holdco Inc. (NYSE:PRTY) rose 8.1% to close at $3.86.
    • WeWork Inc. (NYSE:WE) gained 8.1% to close at $6.41 after Piper Sandler initiated coverage on the stock with an Overweight rating and announced a $10 price target.
    • Pulse Biosciences, Inc. (NASDAQ:PLSE) gained 7.3% to close at $3.38.
    • Sentage Holdings Inc. (NASDAQ:SNTG) rose 6.7% to close at $0.80.
    • Sidus Space, Inc. (NASDAQ:SIDU) rose 6.5% to close at $2.97 following a 7% decline on Monday. Sidus Space recently appointed Teresa Burchfield as its Chief Financial Officer.
    • Zendesk, Inc. (NYSE:ZEN) rose 6.1% to close at $129.12 after Bloomberg late Monday reported the company is working with Qatalyst on a potential sale.


    Losers

    • System1, Inc. (NYSE:SST) shares fell 34.2% to close at $13.45 on Tuesday as the company disclosed a previously-issued (from Feb. 9, 2022) shelf registration statement went into effect.
    • BRC Inc. (NYSE:BRCC) fell 23.1% to close at $17.68.
    • Lyra Therapeutics, Inc. (NASDAQ:LYRA) dipped 20.9% to settle at $5.48.
    • Lyra Therapeutics recently reported a private placement for gross proceeds of $100.5 million.
    • Mawson Infrastructure Group, Inc. (NASDAQ:MIGI) fell 18.7% to close at $4.04. Mawson Infrastructure Group said March self-mined bitcoin production up 336% year over year to 170 bitcoin.
    • Arqit Quantum Inc. (NASDAQ:ARQQ) fell 16.4% to close at $10.45.
    • BitNile Holdings, Inc. (NYSE:NILE) dropped 14.1% to settle at $0.6076. BitNile recently reported FY21 sales results up from last year.
    • Lion Group Holding Ltd. (NASDAQ:LGHL) fell 14% to close at $1.41.
    • Cerberus Cyber Sentinel Corporation (NASDAQ:CISO) declined 13.5% to close at $3.90.
    • DENTSPLY SIRONA Inc. (NASDAQ:XRAY) fell 13.4% to close at $42.20 after the company issued Q1 2022 adjusted EPS guidance below estimates and announced the appointment of John Groetelaars as Interim Chief Executive Officer.
    • Aytu BioPharma, Inc. (NASDAQ:AYTU) fell 12.6% to settle at $0.7975. Aytu BioPharma announced Fast Track designation was granted for AR101 for the treatment of vascular Ehlers-Danlos syndrome.
    • CEL-SCI Corporation (NYSE:CVM) dipped 12% to close at $3.23.
    • Cassava Sciences, Inc. (NASDAQ:SAVA) shares fell 11.3% to close at $22.46.
    • Enservco Corporation (NYSE:ENSV) fell 10.5% to close at $3.25. Enservco shares gained 38% on Monday after the company announced the delay of its 2021 10-K filing to adjust for its utilization of certain deferred tax liabilities in 2021.
    • Houston American Energy Corp. (NYSE:HUSA) dropped 10% to settle at $4.50.
    • Jupai Holdings Limited (NYSE:JP) fell 10% to close at $0.54.
    • MoonLake Immunotherapeutics (NASDAQ:MLTX) fell 7.9% to close at $5.52.
    • Casa Systems, Inc. (NASDAQ:CASA) fell 7.9% to close at $6.54. Casa Systems shares jumped over 82% on Monday after the company announced a multi-year contract with Verizon to provide 5G core network functions. Verizon will also make an investment of approximately $40 million in Casa, resulting in a 9.9% ownership stake.
    • FLEX LNG Ltd. (NYSE:FLNG) shares fell 7.9% to close at $29.28.
    • Energy Vault Holdings, Inc. (NYSE:NRGV) fell 7.4% to settle at $13.00.
    • U.S. Energy Corp. (NASDAQ:USEG) fell 8.4% to close at $4.58.
    • Indonesia Energy Corporation Limited (NYSE:INDO) shares fell 6.6% to close at $24.09.
    • Barnwell Industries, Inc. (NYSE:BRN) dropped 5.4% to close at $2.65.
    Get the next $ACC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACC
    $AIM
    $ANNX
    $ARQQ

    CompanyDatePrice TargetRatingAnalyst
    Candel Therapeutics Inc.
    $CADL
    4/20/2026Overweight
    Cantor Fitzgerald
    DENTSPLY SIRONA Inc.
    $XRAY
    4/15/2026$10.00Sell
    Citigroup
    ThredUp Inc.
    $TDUP
    4/6/2026$5.00Buy
    TD Cowen
    Regeneron Pharmaceuticals Inc.
    $REGN
    3/31/2026$875.00Overweight
    Piper Sandler
    Olema Pharmaceuticals Inc.
    $OLMA
    3/27/2026Peer Perform
    Wolfe Research
    Super Micro Computer Inc.
    $SMCI
    3/23/2026$22.00Outperform → Market Perform
    Northland Capital
    Super Micro Computer Inc.
    $SMCI
    3/20/2026Buy → Hold
    Argus
    Super Micro Computer Inc.
    $SMCI
    3/20/2026Market Perform → Market Underperform
    CJS Securities
    More analyst ratings

    $ACC
    $AIM
    $ANNX
    $ARQQ
    SEC Filings

    View All

    SEC Form DEFA14A filed by DENTSPLY SIRONA Inc.

    DEFA14A - DENTSPLY SIRONA Inc. (0000818479) (Filer)

    4/23/26 4:43:35 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    SEC Form DEF 14A filed by DENTSPLY SIRONA Inc.

    DEF 14A - DENTSPLY SIRONA Inc. (0000818479) (Filer)

    4/23/26 4:32:10 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Mawson Infrastructure Group Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Mawson Infrastructure Group Inc. (0001218683) (Filer)

    4/23/26 4:30:22 PM ET
    $MIGI
    Finance: Consumer Services
    Finance

    $ACC
    $AIM
    $ANNX
    $ARQQ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Candel Therapeutics

    Cantor Fitzgerald initiated coverage of Candel Therapeutics with a rating of Overweight

    4/20/26 8:26:00 AM ET
    $CADL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Citigroup initiated coverage on Dentsply Sirona with a new price target

    Citigroup initiated coverage of Dentsply Sirona with a rating of Sell and set a new price target of $10.00

    4/15/26 8:07:52 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    TD Cowen initiated coverage on thredUP with a new price target

    TD Cowen initiated coverage of thredUP with a rating of Buy and set a new price target of $5.00

    4/6/26 8:45:54 AM ET
    $TDUP
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ACC
    $AIM
    $ANNX
    $ARQQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Operating Officer Jacobson Mark L.

    4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)

    4/23/26 9:02:45 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chief Executive Officer Tabuteau Herriot

    4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)

    4/23/26 9:02:29 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Commercial Officer Maizel Ari exercised 7,500 shares at a strike of $70.73 and sold $1,368,150 worth of shares (7,500 units at $182.42) as part of a pre-agreed trading plan (SEC Form 4)

    4 - Axsome Therapeutics, Inc. (0001579428) (Issuer)

    4/23/26 9:01:34 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACC
    $AIM
    $ANNX
    $ARQQ
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for AUVELITY issued to AXSOME THERAPEUTICS, INC.

    Submission status for AXSOME THERAPEUTICS, INC.'s drug AUVELITY (ORIG-1) with active ingredient DEXTROMETHORPHAN HYDROBROMIDE AND BUPROPION HYDROCHLORIDE has changed to 'Approval' on 08/18/2022. Application Category: NDA, Application Number: 215430, Application Classification: Type 3 - New Dosage Form and Type 4 - New Combination

    8/19/22 12:36:14 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    May 20, 2022 - FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder

    For Immediate Release: May 20, 2022 Today, the U.S. Food and Drug Administration approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in adults and pediatric patients 12 years and older weighing at least 40 kilograms (which is about 88 pounds). Today’s action marks the first FDA approval of a treatment for EoE. “As researchers and clinicians have gained knowledge about eosinophilic esophagitis

    5/20/22 3:11:09 PM ET
    $REGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for GIMOTI

    Submission status for EVOKE PHARMA INC's drug GIMOTI (SUPPL-1) with active ingredient METOCLOPRAMIDE HYDROCHLORIDE has changed to 'Approval' on 01/14/2021. Application Category: NDA, Application Number: 209388, Application Classification: Labeling

    1/15/21 5:10:35 AM ET
    $EVOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACC
    $AIM
    $ANNX
    $ARQQ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Points Jeffrey S. exercised 13,264 shares at a strike of $2.48 and bought $30,000 worth of shares (2,000 units at $15.00), increasing direct ownership by 27% to 70,785 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:42:34 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Buchholz Richard bought $14,840 worth of shares (1,000 units at $14.84), increasing direct ownership by 8% to 13,666 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:34:29 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    CEO & Executive Chairman Ball Robert Joseph bought $33,392 worth of shares (2,200 units at $15.18), increasing direct ownership by 0.80% to 278,866 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:31:09 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $ACC
    $AIM
    $ANNX
    $ARQQ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    U.S. Energy Corp. Schedules First Quarter 2026 Conference Call for May 7, 2026 at 9:00 a.m. ET

    HOUSTON, April 23, 2026 (GLOBE NEWSWIRE) -- U.S. Energy Corp. (NASDAQ:USEG) ("U.S. Energy" or the "Company"), an integrated energy company advancing a diversified industrial gas, energy, and carbon management platform, will host a conference call on Thursday, May 7, 2026, at 9:00 a.m. Eastern Time/8:00 a.m. Central Time to discuss its financial results for the first quarter ended March 31, 2026. The Company's results will be reported in a press release prior to the call.. U.S. Energy's management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions prior to the call by emailing the Company's investor relations team at [email protected]

    4/23/26 4:42:38 PM ET
    $USEG
    Oil & Gas Production
    Energy

    Mawson Infrastructure Group Inc. Becomes Big Digital Energy, Inc.; Receives Nasdaq Listing Determination; Already in Compliance, To Request Hearing

    MIDLAND, Pa., April 23, 2026 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (the "Company") (NASDAQ:MIGI) today announced that it has submitted the relevant documentation with the State of Delaware to update its name to Big Digital Energy, Inc., effective April 24, 2026, and that, subject to approval by Nasdaq, its common stock is expected to begin trading on The Nasdaq Capital Market ("Nasdaq") under the ticker symbol "BGDE" upon market open on April 30, 2026. The Company's CUSIP number will remain unchanged, and no action is required from stockholders in relation to this change. Phil Stanley, Chief Executive Officer of Mawson, commented, "The transition to Big Digital Energy and o

    4/23/26 4:15:00 PM ET
    $MIGI
    Finance: Consumer Services
    Finance

    Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S.

    Regeneron will provide Otarmeni™ (lunsotogene parvec-cwha), its recently approved gene therapy for an ultra-rare form of genetic hearing loss, for free in the U.S. Regeneron will lower Medicaid prices based on prices in other developed countries; prices for future medicines in the U.S. will be aligned with prices set in that defined group of other countries Praluent® (alirocumab), an important cardiovascular medicine, will be available for direct patient purchase through TrumpRx.gov Regeneron will continue its large investment in domestic R&D and manufacturing capacity TARRYTOWN, N.Y., April 23, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced an

    4/23/26 3:46:16 PM ET
    $REGN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACC
    $AIM
    $ANNX
    $ARQQ
    Leadership Updates

    Live Leadership Updates

    View All

    Tomorrow Street, a joint venture between Vodafone and Luxembourg's technology incubator, chooses Arqit to add Quantum Security Solutions to its portfolio

    LONDON, April 16, 2026 (GLOBE NEWSWIRE) -- Arqit (NASDAQ:ARQQ, ARQQW)), a global leader in PQC migration tooling and quantum-safe encryption, has been selected to join the Tomorrow Street portfolio as a Scaleup Partner. Arqit is the first quantum security company to join the portfolio. This milestone follows Arqit's participation in Tomorrow Street's 2025 Scaleup X programme, where it engaged with technology stakeholders and demonstrated the relevance of its solutions in addressing emerging cybersecurity challenges across Tomorrow Street's ecosystem. As part of the portfolio, Arqit joins a group of technology companies working across areas such as data, security, and digital infrastructu

    4/16/26 9:00:00 AM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology

    Pulse Biosciences Strengthens Executive Leadership Team

    Appoints Liane Teplitsky as Chief Operating Officer Expands Dr. David Kenigsberg's Chief Medical Officer Role Pulse Biosciences, Inc. (NASDAQ:PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced the strengthening of its executive leadership team with the appointment of Liane Teplitsky as Chief Operating Officer and expanded role of Dr. David Kenigsberg as full-time Chief Medical Officer. Both the appointment of Liane Teplitsky as Chief Operating Officer and Dr. David Kenigsberg's agreement to serve as the Company's Chief Medical Officer on a full-time basis further enhance the Company's strategic alignment to priori

    4/9/26 7:00:00 AM ET
    $PLSE
    Medical/Dental Instruments
    Health Care

    Super Micro Computer Announces Resignation of Board Member Yih-Shyan "Wally" Liaw

    DeAnna Luna Appointed Acting Chief Compliance OfficerSAN JOSE, Calif., March 20, 2026 /PRNewswire/ -- Super Micro Computer, Inc. (NASDAQ:SMCI) ("Supermicro" or the "Company") today announced that Yih-Shyan "Wally" Liaw ("Mr. Liaw") has resigned from the Company's Board of Directors, effective immediately. Following Mr. Liaw's resignation, the Company's Board comprises eight directors. There are no changes to the Board's committee structure. The Company also announced today that it has appointed DeAnna Luna as acting Chief Compliance Officer, effective immediately. Ms. Luna brings to this role more than two decades of experience in global trade compliance, governance, highly regulated markets

    3/20/26 4:38:00 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    $ACC
    $AIM
    $ANNX
    $ARQQ
    Financials

    Live finance-specific insights

    View All

    U.S. Energy Corp. Schedules First Quarter 2026 Conference Call for May 7, 2026 at 9:00 a.m. ET

    HOUSTON, April 23, 2026 (GLOBE NEWSWIRE) -- U.S. Energy Corp. (NASDAQ:USEG) ("U.S. Energy" or the "Company"), an integrated energy company advancing a diversified industrial gas, energy, and carbon management platform, will host a conference call on Thursday, May 7, 2026, at 9:00 a.m. Eastern Time/8:00 a.m. Central Time to discuss its financial results for the first quarter ended March 31, 2026. The Company's results will be reported in a press release prior to the call.. U.S. Energy's management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions prior to the call by emailing the Company's investor relations team at [email protected]

    4/23/26 4:42:38 PM ET
    $USEG
    Oil & Gas Production
    Energy

    Dentsply Sirona to Host First Quarter 2026 Conference Call on May 5

    CHARLOTTE, N.C., April 22, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will host an investor conference call and live webcast on Tuesday, May 5, 2026, at 4:30 p.m. ET to review its first quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call. Conference Call / Webcast Information The live webcast link and call information will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the c

    4/22/26 4:15:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

    GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domesti

    4/22/26 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $ACC
    $AIM
    $ANNX
    $ARQQ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by AIM ImmunoTech Inc.

    SC 13D/A - AIM ImmunoTech Inc. (0000946644) (Subject)

    12/17/24 4:11:23 PM ET
    $AIM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Candel Therapeutics Inc.

    SC 13G - Candel Therapeutics, Inc. (0001841387) (Subject)

    12/17/24 12:30:40 PM ET
    $CADL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Lyra Therapeutics Inc.

    SC 13D/A - Lyra Therapeutics, Inc. (0001327273) (Subject)

    12/16/24 9:02:59 PM ET
    $LYRA
    Medical/Dental Instruments
    Health Care